Low T, High Hurdles: Why Doctors Don't Always Prescribe Testosterone

Physician-reviewed TRT access guide

Why Won’t My Doctor Prescribe Testosterone?

A doctor may decline TRT because the diagnosis is not yet confirmed, another condition may explain the symptoms, fertility is a concern, a contraindication is present, or the clinician believes the risks outweigh the expected benefit.

Medically reviewed by Dr. Timothy Mackey
Medical Director · Updated September 2026

1. Low testosterone has to be confirmed

Major guidelines recommend diagnosing testosterone deficiency only when compatible symptoms or signs are present together with consistently low testosterone concentrations.

The American Urological Association uses total testosterone below 300 ng/dL as a reasonable diagnostic cutoff, but a single low result is generally not enough. Repeat morning testing on a separate day is commonly recommended before long-term treatment is started.

See our guide to blood tests before TRT.

2. Symptoms may have another cause

Fatigue, low libido, erectile dysfunction, poor concentration, low mood, reduced exercise capacity and weight gain are not unique to testosterone deficiency. Sleep apnea, obesity, thyroid disease, anemia, diabetes, depression, chronic illness, medications, alcohol and sleep deprivation can produce similar symptoms.

A clinician may want to investigate these possibilities before prescribing testosterone because treating the wrong diagnosis can delay appropriate care.

3. “Normal” total testosterone does not always settle the question

Total testosterone can be harder to interpret when sex hormone-binding globulin (SHBG) is unusually high or low. In selected men with borderline total testosterone, an appropriately measured or calculated free testosterone can provide additional context.

That does not mean every symptomatic man with a “normal” total testosterone has hidden hypogonadism. Free testosterone is one piece of the diagnostic picture, not a loophole around proper criteria.

4. Fertility can change the decision

Exogenous testosterone suppresses LH and FSH and can markedly reduce sperm production. A man who wants current or future biological children may be advised not to start standard TRT, at least until fertility goals are addressed.

Alternative approaches may be considered in selected men depending on the cause of low testosterone. See TRT and fertility.

5. Some medical conditions require caution or further evaluation

TRT may need to be delayed or avoided in men with certain conditions, including markedly elevated hematocrit, untreated severe obstructive sleep apnea, uncontrolled heart failure, recent major cardiovascular events, thrombophilia, or concerning prostate findings that have not been evaluated.

Known or suspected prostate or breast cancer also changes the treatment decision substantially and may require specialist involvement.

6. Hematocrit may already be too high

Testosterone stimulates red-blood-cell production. The AUA recommends checking hemoglobin and hematocrit before treatment. If baseline hematocrit is elevated, the cause should be evaluated before starting TRT.

During treatment, hematocrit of 54% or higher warrants intervention. Read our detailed guide to hematocrit on TRT.

7. Prostate findings may need evaluation first

Current evidence has not established that appropriately prescribed TRT causes prostate cancer, but an abnormal PSA or concerning prostate finding should not be ignored.

Depending on age and risk, a clinician may recommend PSA testing, repeat testing, examination or urology evaluation before treatment. See TRT and prostate cancer risk.

8. Cardiovascular guidance has changed—but not to “zero risk”

Older testosterone labeling included a boxed warning about possible cardiovascular risk. In 2025, FDA removed that boxed warning after reviewing evidence including the TRAVERSE trial, which found testosterone noninferior to placebo for major adverse cardiovascular events in the studied population.

At the same time, FDA required class-wide labeling about increases in blood pressure. The correct takeaway is that the cardiovascular evidence is more reassuring than it once was—not that TRT is risk-free or appropriate for everyone.

9. Some clinicians are simply not comfortable managing TRT

Primary-care physicians vary widely in experience with testosterone deficiency. Some are comfortable diagnosing and managing TRT; others prefer referral to endocrinology, urology or a clinician with more focused hormone experience.

That is not necessarily a deficiency in care. TRT requires long-term follow-up, dose adjustment, interpretation of formulation-specific blood levels and monitoring of hematocrit, blood pressure, prostate risk and adverse effects.

10. A doctor may be concerned about non-medical use

TRT is intended to treat appropriately diagnosed testosterone deficiency—not bodybuilding, athletic enhancement or a short “cycle.” Requests for supraphysiologic dosing or performance-enhancement goals may appropriately lead a clinician to decline treatment.

A reputable TRT program should be willing to say no when the medical indication is not there.

11. Monitoring is part of the prescription

Starting testosterone is only the beginning. Follow-up should assess whether symptoms actually improve, whether testosterone exposure is appropriate for the formulation, and whether side effects develop.

Common monitoring includes CBC/hematocrit, blood pressure and testosterone levels, with PSA/prostate assessment and other testing when appropriate. See our TRT side effects guide.

When is a second opinion reasonable?

A second opinion can be reasonable when symptoms are persistent, the initial workup was incomplete, only one testosterone measurement was obtained, borderline results were not interpreted in context, or the clinician is uncomfortable managing TRT and has not offered referral.

A second opinion should still begin with diagnosis, not with an assumption that testosterone must be prescribed. Our testosterone prescription and evaluation guide explains the usual steps.

What should you bring to a second-opinion visit?

• Prior testosterone results with dates and collection times.
• Medication and supplement list.
• CBC/hematocrit, PSA and other relevant labs.
• History of sleep apnea, cardiovascular disease or fertility plans.
• A clear description of symptoms and when they began.
• Any prior testosterone or anabolic-steroid use.

Frequently asked questions

Can a doctor refuse to prescribe testosterone even if my level is low?

Yes. A low result still has to be interpreted with symptoms, repeat testing, medical history and contraindications. A clinician may also refer rather than prescribe if the case is outside their comfort level.

What if my total testosterone is above 300 but I still have symptoms?

Other causes should be considered. In selected cases, SHBG and free testosterone can add useful information, but symptoms alone do not establish testosterone deficiency.

Can I get TRT just because I am over 50?

No. Age alone is not an indication. See our guide to testosterone after age 50.

Is TRT legally controlled?

Yes. Testosterone is a Schedule III controlled substance in the United States and requires a legitimate medical prescription. State and federal prescribing rules apply.

Does a second opinion mean “doctor shopping”?

No. Seeking another qualified medical opinion is reasonable when a diagnosis is uncertain or the first clinician recommends referral. The problem is seeking prescriptions from multiple clinicians without coordinated care or concealing prior treatment.

Medical references

• American Urological Association: Testosterone Deficiency Guideline
• Endocrine Society: Testosterone Therapy in Men With Hypogonadism
• FDA: Class-wide testosterone labeling changes
• TRAVERSE: Cardiovascular Safety of Testosterone-Replacement Therapy

This article is educational and does not guarantee eligibility for testosterone therapy. Treatment decisions require individualized medical evaluation.